drugset / Trial / NCT00239902

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239902

Phase 2 Completed 396 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney transplant.

Timeline

Start
2002-05
Primary completion
2004-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule

Indications

No indication recorded.